S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
Clinical trial NCT00445848 · COMPLETED
Trial details
- NCT number
- NCT00445848
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2013-08-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.